445 related articles for article (PubMed ID: 18423667)
1. Effectiveness of lamotrigine in bipolar disorder in a clinical setting.
Ketter TA; Brooks JO; Hoblyn JC; Champion LM; Nam JY; Culver JL; Marsh WK; Bonner JC
J Psychiatr Res; 2008 Nov; 43(1):13-23. PubMed ID: 18423667
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression.
Ahn YM; Nam JY; Culver JL; Marsh WK; Bonner JC; Ketter TA
Ann Clin Psychiatry; 2011 Feb; 23(1):17-24. PubMed ID: 21318192
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive aripiprazole in treatment-resistant bipolar depression.
Ketter TA; Wang PW; Chandler RA; Culver JL; Alarcon AM
Ann Clin Psychiatry; 2006; 18(3):169-72. PubMed ID: 16923655
[TBL] [Abstract][Full Text] [Related]
5. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients.
Ittasakul P; Johnson KR; Srivastava S; Childers ME; Brooks JO; Hoblyn JC; Ketter TA
J Affect Disord; 2012 Mar; 137(1-3):139-45. PubMed ID: 22240084
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.
Chang JS; Moon E; Cha B; Ha K
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1322-6. PubMed ID: 20673782
[TBL] [Abstract][Full Text] [Related]
8. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
[TBL] [Abstract][Full Text] [Related]
9. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting.
Ketter TA; Brooks JO; Hoblyn JC; Holland AA; Nam JY; Culver JL; Marsh WK; Bonner JC
J Psychiatr Res; 2010 Oct; 44(14):921-9. PubMed ID: 20378127
[TBL] [Abstract][Full Text] [Related]
10. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
[TBL] [Abstract][Full Text] [Related]
11. Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Hooshmand F; Miller S; Dore J; Wang PW; Hill SJ; Portillo N; Ketter TA
J Affect Disord; 2014 Feb; 155():283-7. PubMed ID: 24314912
[TBL] [Abstract][Full Text] [Related]
12. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine in patients with bipolar disorder and cocaine dependence.
Brown ES; Nejtek VA; Perantie DC; Orsulak PJ; Bobadilla L
J Clin Psychiatry; 2003 Feb; 64(2):197-201. PubMed ID: 12633129
[TBL] [Abstract][Full Text] [Related]
14. Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder.
Miller S; Ittasakul P; Wang PW; Hill SJ; Childers ME; Rasgon N; Ketter TA
J Clin Psychopharmacol; 2012 Dec; 32(6):814-9. PubMed ID: 23131875
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
[TBL] [Abstract][Full Text] [Related]
16. Effects of lamotrigine in patients with bipolar disorder and alcohol dependence.
Rubio G; López-Muñoz F; Alamo C
Bipolar Disord; 2006 Jun; 8(3):289-93. PubMed ID: 16696832
[TBL] [Abstract][Full Text] [Related]
17. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.
Bramness JG; Grøholt B; Engeland A; Furu K
J Affect Disord; 2009 Oct; 117(3):208-11. PubMed ID: 19189871
[TBL] [Abstract][Full Text] [Related]
18. Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review.
Sharma V; Khan M; Corpse C
J Affect Disord; 2008 Nov; 111(1):100-5. PubMed ID: 18314200
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia.
Sajatovic M; Ramsay E; Nanry K; Thompson T
Int J Geriatr Psychiatry; 2007 Oct; 22(10):945-50. PubMed ID: 17326238
[TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
